User beamtime1

Member for: 1 day (since May 19)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/azd5363.html
About: Maintained reply to brigatinib in a affected person using refractory metastatic pheochromocytoma holding R1192P anaplastic lymphoma kinase mutation: an incident document in the Austrian Group Medical Growth Remedy next-generation sequencing pc registry along with discussion with the literature.

Activity by beamtime1

Score: 100 points (ranked #992)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes
...